WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2006090921) INHIBITORY EFFECT OF SULFONAMIDE COMPOUND ON LYMPHOCYTE ACTIVATION
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2006/090921    International Application No.:    PCT/JP2006/304195
Publication Date: 31.08.2006 International Filing Date: 28.02.2006
IPC:
A61K 31/18 (2006.01), A61K 31/343 (2006.01), A61K 31/381 (2006.01), A61K 31/404 (2006.01), A61K 31/47 (2006.01), A61K 31/498 (2006.01), A61K 31/64 (2006.01), A61K 39/395 (2006.01), A61K 45/00 (2006.01), A61P 1/04 (2006.01), A61P 3/00 (2006.01), A61P 3/10 (2006.01), A61P 25/00 (2006.01), A61P 29/00 (2006.01), A61P 35/00 (2006.01), A61P 35/02 (2006.01), A61P 37/02 (2006.01), A61P 43/00 (2006.01), C07D 241/44 (2006.01), C07D 307/79 (2006.01), C07D 333/34 (2006.01)
Applicants: EISAI R & D MANAGEMENT CO., LTD. [JP/JP]; 6-10, Koishikawa 4-chome, Bunkyo-ku, Tokyo 1128088 (JP) (For All Designated States Except US).
OWA, Takashi [JP/JP]; (JP) (For US Only).
OZAWA, Yoichi [JP/JP]; (JP) (For US Only).
ONO, Naoto [JP/JP]; (JP) (For US Only)
Inventors: OWA, Takashi; (JP).
OZAWA, Yoichi; (JP).
ONO, Naoto; (JP)
Agent: KOBAYASHI, Hiroshi; c/o ABE, IKUBO & KATAYAMA Fukuoka Bldg. 9th Fl. 8-7, Yaesu 2-chome Chuo-ku, Tokyo 104-0028 (JP)
Priority Data:
2005-054475 28.02.2005 JP
Title (EN) INHIBITORY EFFECT OF SULFONAMIDE COMPOUND ON LYMPHOCYTE ACTIVATION
(FR) EFFET D'INHIBITION D'UN COMPOSÉ DE SULFAMIDE SUR L'ACTIVATION DE LYMPHOCYTES
(JA) スルホンアミド化合物のリンパ球活性化抑制作用
Abstract: front page image
(EN)A lymphocyte activation inhibitor and a remedy for an autoimmune disease comprising a sulfonamide compound as an active ingredient.
(FR)La présente invention concerne un inhibiteur d'activation de lymphocytes et un remède pour une maladie auto-immunitaire, dont l'ingrédient actif est du sulfamide.
(JA)本発明は、スルホンアミド化合物を有効成分として含むリンパ球活性化抑制剤および自己免疫疾患の治療剤に関する。
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: Japanese (JA)
Filing Language: Japanese (JA)